APOE ε4 Carrier Status as Mediator of Effects of Psychotropic Drugs on Clinical Changes in Patients With Alzheimer’s Disease-Reference-Cited by-同舟云学术

APOE ε4 Carrier Status as Mediator of Effects of Psychotropic Drugs on Clinical Changes in Patients With Alzheimer’s Disease

Published:2022-10 Issue:4 Volume:34 Page:351-360
ISSN:0895-0172
Container-title:The Journal of Neuropsychiatry and Clinical Neurosciences
language:en
Short-container-title:JNP

Author:

de Oliveira Fabricio Ferreira¹,de Almeida Sandro Soares¹,Chen Elizabeth Suchi¹,Smith Marilia Cardoso¹,Bertolucci Paulo Henrique Ferreira¹

Affiliation:

1. Department of Neurology and Neurosurgery (de Oliveira, Bertolucci), Department of Biophysics (de Almeida), Department of Morphology and Genetics (Chen, Smith), Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil.

Publisher

American Psychiatric Association Publishing

Subject

Psychiatry and Mental health,Neurology (clinical)

Reference53 articles.

1. Assessment of sleep satisfaction in patients with dementia due to Alzheimer’s disease

2. Lifetime Risk Factors for Functional and Cognitive Outcomes in Patients with Alzheimer’s Disease

3. Associations of Blood Pressure with Functional and Cognitive Changes in Patients with Alzheimer's Disease

4. Predictors of Cognitive and Functional Decline in Patients With Alzheimer Disease Dementia From Brazil

5. The Genetics of the Human APOE Polymorphism

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Shedding Light on the Effects of Blood Pressure on Cognitive Decline and Dementia Risk by Way of Neurobiological Evidence;Journal of Alzheimer's Disease;2024-05-14

2. Pharmacogenetics of angiotensin modulators according to APOE-ϵ4 alleles and the ACE insertion/deletion polymorphism in Alzheimer’s disease;Acta Neuropsychiatrica;2023-08-22

3. Looking Behind the Curtain: Patient Stratification According to Genetic or Demographic Factors May Yield Unexpected Results in Studies of Neurodegenerative Diseases;Journal of Alzheimer's Disease;2023-07-18

4. Psychosis as a Treatment Target in Dementia: A Roadmap for Designing Interventions;Journal of Alzheimer's Disease;2022-08-16